Martin Biosse-Duplan, a former Harvard dental school research fellow found by the Office of Research Integrity to have falsified results has had the two papers in question retracted.
From the Journal of Bone and Mineral Research: Continue reading Two retractions appear for former Harvard dental researcher found to have committed misconduct
Last month, we covered the retraction of a paper by A.M.K. El-Ghonemy, of Al-Jouf University in Saudi Arabia. The engineer now has a second retraction in the same journal, Renewable and Sustainable Energy Reviews.
Here’s the notice for “Waste energy recovery in sea water reverse osmosis desalination plants, Part-1: Review”: Continue reading Saudi engineer loses second fresh water paper for plagiarism
A team of neuroscientists in Japan has lost their 2012 article in Brain Research for duplicating elements of a figure from a paper they’d published earlier that year in another journal.
The article, “Dynamic changes of mitochondrial fission proteins after transient cerebral ischemia in mice,” came from a lab at Okayama University. The last author was Koji Abe. According to the retraction notice:
Continue reading Mitochondrial fission paper falls for fusing data from earlier work
Talanta, a journal serving the analytical chemistry community — we’d love to know how the name came to be — has retracted a 2013 article by a group of Indian researchers over an authorship dispute.
The paper, “Non-enzymatic electrochemical glucose sensor based on silver/silver oxide nano-rods reinforced with multiwall carbon nanotubes,” appeared in January, with the authors listed as Leila Shahriary, Santosh K. Haram and Anjali A. Athawale.
But according to the retraction notice:
Continue reading “Conflicts among the authors” force retraction of Talanta paper
Math journal editors can add — but they can also subtract.
That’s what happened to a 2012 paper in the Journal of Mathematical Analysis and Applications (JMAA), “On the fractional Ostrowski inequality with uncertainty.”
Here’s the notice: Continue reading Oops: Math journal retracts paper accepted by “accidental administrative error”
Coding errors in a database maintained by Pfizer have led authors to retract two heart biomarker papers in the Journal of the American College of Cardiology.
The two notices, for “Prediction of cardiovascular events in statin-treated patients by lipid and non-lipid biomarkers” and “Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) Trial,” are highly detailed and say the same thing: Continue reading Pfizer database errors cause two voluminous retractions for JACC statin-biomarker papers
Back in January, we wrote about the retraction of a paper in the International Journal of Radiation Oncology *Biology* Physics, the first from that journal in its 38-year history.
At the time, the journal’s new editor, Anthony Zietman, of Mass General, told us that he was working on a second retraction. That one has arrived.
The paper, “High-Dose Conformal Radiotherapy Reduces Prostate Cancer–Specific Mortality: Results of a Meta-analysis,” came from a team of radiation oncologists in Brazil, and was published last August.
According to the retraction notice:
Continue reading Without “confidence in the conclusions,” group retracts prostate cancer paper
Markets undergo flash crashes — when stocks or bonds rapidly nosedive in value and then just as rapidly recover — every day. On May 6, 2010, for example, the entire equity market flamed out and then nearly recovered its value all in the matter of hours.
Economic papers can do the same, apparently. Take the recent withdrawal of an paper from the Journal of Financial Markets: Continue reading Markets crash, and so does a paper explaining why
A group of veterinary researchers from Taiwan has lost their 2012 paper in the Journal of Chromatography B for misuse of propriety material.
What that means we’re not quite sure, but we have a guess.
The article, “Pilot production of recombinant human clotting factor IX from transgenic sow milk,” was published last July by four scientists at the Animal Technology Institute of Taiwan.
But, as the retraction notice explains, the paper didn’t stick:
Continue reading Misuse of data forces retraction of paper on sow’s milk
A potential weight loss drug has been dealt what could be a serious setback after regulators found problems at two trial sites.
While awaiting a final report, The Lancet, which published a study of the drug, tesofensine, has issued an Expression of Concern: Continue reading Trial irregularities earn Lancet study of potential weight loss drug tesofensine Expression of Concern